dapagliflozin
astrazeneca
['dapagliflozin', 'cardio']
#esccongress #jacc lbct simpub: modeling from the #deliver trial suggests #sglt2i dapagliflozin may extend event-free survival by up to 2-2.5 years in #hfmref or #hfpef. #dapagliflozin #cardiotwitter 
Official Twitter account of the #JACCJournals, the world’s leading peer-reviewed cardiovascular journals and websites. @ACCinTouch #JACC #CardioTwitter